Literature DB >> 21235262

Total synthesis of microcin B17 via a fragment condensation approach.

Robert E Thompson1, Katrina A Jolliffe, Richard J Payne.   

Abstract

The total synthesis of the 43 amino acid antibacterial peptide Microcin B17 (MccB17) is described. The natural product was synthesized via a convergent approach from a heterocycle-derived peptide and peptide thioester fragments prepared via Fmoc-strategy solid phase peptide synthesis (SPPS). Final assembly was achieved in an efficient manner using two Ag(I)-assisted peptide ligation reactions to afford MccB17 in excellent overall yield.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235262     DOI: 10.1021/ol102916b

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

Review 1.  YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.

Authors:  Brandon J Burkhart; Christopher J Schwalen; Greg Mann; James H Naismith; Douglas A Mitchell
Journal:  Chem Rev       Date:  2017-03-03       Impact factor: 60.622

Review 2.  Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

Authors:  Frédéric Collin; Shantanu Karkare; Anthony Maxwell
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-09       Impact factor: 4.813

3.  Fragments of the bacterial toxin microcin B17 as gyrase poisons.

Authors:  Frédéric Collin; Robert E Thompson; Katrina A Jolliffe; Richard J Payne; Anthony Maxwell
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

4.  Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction.

Authors:  Jun Huang; Yingnan Cao; Xianzhang Bu; Changyou Wu
Journal:  BMC Immunol       Date:  2012-09-10       Impact factor: 3.615

Review 5.  Naturally Occurring Oxazole-Containing Peptides.

Authors:  Jessica T Mhlongo; Edikarlos Brasil; Beatriz G de la Torre; Fernando Albericio
Journal:  Mar Drugs       Date:  2020-04-10       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.